Table 1.
Characteristics of hepatitis C patients and controls.
| Patient | Age (years) | Sex | ALT | Viral load log (eq/ml) | Genotype | IL-8 conc. (pg/ml) | TNF-α conc. (pg/ml) |
|---|---|---|---|---|---|---|---|
| HCV PCR+ | 33 | M | 73 | 6·238 | 1b | 26·049 | 27·092 |
| 51 | M | 177 | 6·138 | 3a | 67·342 | 14·589 | |
| 71 | F | 89 | 6·031 | 1a | 53·957 | 11·572 | |
| 40 | M | 33 | 6·146 | 1b | 48·871 | 17·176 | |
| 23 | M | 88 | 5·954 | 1 | 22·647 | 26·488 | |
| 53 | M | 51 | 5·942 | 1b | 42·103 | 12·488 | |
| 25 | M | 64 | 6·169 | 2 | 67·970 | 28·069 | |
| 43 | M | 105 | 6·860 | 4 | 71·757 | 25·757 | |
| 58 | F | 116 | 7·011 | 1 | 69·985 | 27·005 | |
| HCV PCR– | 30 | M | 21 | n.a. | 13·779 | 5·093 | |
| 37 | M | 10 | n.a. | 6·696 | 4·251 | ||
| 48 | M | 9 | n.a. | 14·804 | 4·554 | ||
| 35 | M | 30 | n.a. | 16·921 | 8·418 | ||
| 70 | F | 30 | n.a. | 9·304 | 5·102 | ||
| Controls | 24 | F | 0·492 | 0·744 | |||
| 34 | M | 0·518 | 0·891 | ||||
| 33 | M | 0·865 | 0·697 | ||||
| 30 | F | 0·429 | 0·560 | ||||
| 29 | F | 0·605 | 1·028 | ||||
| 29 | M | 0·979 | 0·693 | ||||
| 33 | M | 0·903 | 0·688 | ||||
| 29 | M | 0·936 | 1·551 | ||||
| 31 | F | 0·479 | 0·643 | ||||
| 31 | F | 0·645 | 0·753 |
ALT = alanine aminotransferase; IL = interleukin; n.a. = not applicable; PCR = polymerase chain reaction; TNF = tumour necrosis factor; M = male; F = female.